Chen GL, Liu Y, Gao XF, Wu KQ, et al. Safety, tolerability, pharmacokinetic, pharmacodynamic and immunogenicity profiles of Exendin-4-IgG4-Fc in healthy subjects: A phase 1, single-centre, randomized, double-blind, dose escalation study. Diabetes Obes Metab 2024;26:1395-1406.
PMID: 38287130